PRO 2000 elicits a decline in genital tract immune mediators without compromising intrinsic antimicrobial activity

Abstract

In contrast to experience with nonoxynol-9, PRO 2000 did not trigger an inflammatory response in cervicovaginal secretions. There was a modest reduction in mucosal immune mediators, but this loss was not associated with a reduction in intrinsic antimicrobial activity.